Professor Dr. Joseph Fortunak brings exceptional academic credentials and transformative industry experience to the Board of Directors at DASHA Pharmaceuticals. After earning his PhD at the prestigious University of Wisconsin-Madison and completing his post-doctoral fellowship at Cambridge University, Dr. Fortunak developed into a scientific leader of remarkable versatility. His career trajectory exemplifies rare breadth—evolving from a pioneering laboratory scientist who invented novel chemistry and chemical processes to a visionary executive who skillfully managed up to 500 professionals, including 300 PhD-level scientists. Dr. Fortunak’s scientific acumen and strategic oversight have directly contributed to remarkable healthcare advancements, including the successful launch of 15 groundbreaking new medicines and over 25 generic products that expanded treatment access. This powerful combination of scientific innovation and executive leadership enables him to provide DASHA Pharmaceuticals with invaluable guidance bridging cutting-edge research, operational excellence, and strategic market positioning.